Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 85 results found. Search for [ drug pricing regulator ]

Results 20 to 40 of 85
E Kumar Sharma
New Delhi, May 25, 2018
Just prior to the results, on May 23, Sun Pharma had announced that the US drug regulator USFDA (US Food and Drug Administration) approved Yonsa, its drug to treat a kind of prostate cancer.


Reuters
May 2, 2018
India's drug pricing authority is also pushing to bring three more devices used while treating heart ailments under the ambit of price controls as they are sometimes more expensive than the stent itself.


PTI
April 2, 2018



PTI
March 18, 2018



PTI
March 8, 2018



PTI
New Delhi, March 4, 2018
National drug pricing regulator NPPA has said medical devices makers and importers are being given the last opportunity to submit data regarding price movement of 19 medical devices notified as drugs by March 15, 2018.


PTI
March 4, 2018



BusinessToday.in
New Delhi, February 13, 2018
In its latest bid to hasten resolution of the bad loans problem at Indian banks, the Reserve Bank of India tightened its rules around bank loan defaults.


PTI
February 12, 2018



E Kumar Sharma
New Delhi, December 28, 2017
 The just concluded year, hurt Indian pharma companies in more ways than one


E Kumar Sharma
December 17, 2017
On Friday, the National Pharmaceutical Pricing Authority without either pronouncing Fortis guilty or absolving it of any wrong doing, just confined itself to saying: \"NPPA shall be taking necessary follow up action as per existing law and within its jurisdiction.\"


E. kumar sharma
New Delhi, December 11, 2017
Indian pharma companies are facing strong headwinds, but they are also exploring every new opportunity to ensure a quick recovery.


E Kumar Sharma
New Delhi, September 1, 2017
An integrated and unified approach in the handling affairs concerning health and medicines in the country, could go a long way in unlocking the huge potential of the industry,says DCGI GN Singh.


Joe C Mathew
New Delhi, August 31, 2017
The Medical Technology Association of India (MTaI), a representative body of the domestic arm of global medical device makers, has asked the drug price regulator National Pharmaceutical Pricing Authority (NPPA) to review its decision to cap the prices of knee implants.


Joe C Mathew
New Delhi, August 18, 2017
NPPA Chairman Bhupendra Singh said that a similar exercise to identify the price patterns prevailing in medical device sector is underway.


Joe C Mathew
New Delhi, August 18, 2017
MTaI argued that knee replacement surgery is not a life-threatening procedure but an elective surgery as the patient is free to choose to go for it or go for alternate therapies.


E Kumar Sharma
New Delhi, July 6, 2017
There have been fresh concerns related to the transition to a Goods and Services Tax (GST) regime. Then, the industry lost one of its leaders - Desh Bandhu Gupta, the 79-year-old founder and chairman of Lupin.


Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.


PTI
New Delhi, June 13, 2017
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.


E. Kumar Sharma
New Delhi, June 10, 2017
Dr. Reddy's says it has a plan and a product pipeline to drive growth in spite of regulatory and other challenges. Can it pull it off?


PAGES 2 OF 5  12345